eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | al amyloidosis |
| Comorbidity | C0878544|cardiomyopathy |
| Sentences | 2 |
| PubMedID- 22244725 | Bortezomib-based regimens are commonly employed as first-line treatment in myeloma cast nephropathy and randall-type monoclonal ig deposition disease and as second line therapy in al amyloidosis patients with advanced cardiomyopathy or refractory to previous chemotherapy. |
| PubMedID- 22504167 | Objectives: restrictive cardiomyopathy due to al amyloidosis has not been reported as the cause of sudden death. |
Page: 1